Dyne Therapeutics Inc (NASDAQ: DYN) closed the day trading at $26.78 up 3.52% from the previous closing price of $25.87. In other words, the price has increased by $+0.91 from its previous closing price. On the day, 1150802 shares were traded. DYN stock price reached its highest trading level at $27.11 during the session, while it also had its lowest trading level at $25.97.
Ratios:
For a better understanding of DYN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 20, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On February 27, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $16 to $27.
On February 15, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $34.Oppenheimer initiated its Outperform rating on February 15, 2023, with a $34 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 01 ’24 when Brumm Joshua T sold 94,480 shares for $29.04 per share. The transaction valued at 2,743,718 led to the insider holds 563,471 shares of the business.
Rhodes Jason P sold 46,534 shares of DYN for $1,398,347 on Mar 01 ’24. The Director now owns 847,388 shares after completing the transaction at $30.05 per share. On Mar 01 ’24, another insider, Atlas Venture Opportunity Fund, who serves as the 10% Owner of the company, sold 29,435 shares for $30.05 each. As a result, the insider received 884,522 and left with 1,458,691 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 2.12B and an Enterprise Value of 2.02B.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $30.27, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 19.90, while the 200-Day Moving Average is calculated to be 12.92.
Shares Statistics:
Over the past 3-months, DYN traded about 1.96M shares per day on average, while over the past 10 days, DYN traded about 1.5M shares per day. A total of 61.47M shares are outstanding, with a floating share count of 39.70M. Insiders hold about 51.05% of the company’s shares, while institutions hold 52.76% stake in the company. Shares short for DYN as of Feb 15, 2024 were 7.25M with a Short Ratio of 3.69, compared to 7.97M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.94% and a Short% of Float of 11.18%.
Earnings Estimates
Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$0.72 for the current quarter, with a high estimate of -$0.58 and a low estimate of -$0.83, while EPS last year was -$0.78. The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.57 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$2.29 and -$3.76 for the fiscal current year, implying an average EPS of -$3.17. EPS for the following year is -$2.63, with 6 analysts recommending between -$2.29 and -$2.92.
